文献速递头颈外科咽喉与嗓音

经口机器人手术后经验证的生活质量与吞咽结局的系统综述

Systematic Review of Validated Quality of Life and Swallow Outcomes after Transoral Robotic Surgery.
PubMed 文献 · Otolaryngol Head Neck Surg · 2019-04-23

该综述检索PubMed和Ovid数据库至2016年7月6日,纳入20篇文章共659例头颈癌患者,评估经口机器人手术(TORS)后生活质量与吞咽功能。多数患者报告在治疗后6至12个月恢复基线水平,部分研究显示TORS优于放化疗或开放手术。

要点

  • 多数TORS患者报告在治疗后6至12个月恢复基线生活质量和吞咽功能。
  • 部分研究显示TORS在生活质量和吞咽结局上优于首选放化疗或开放手术。
  • 结局取决于基线功能、T分期和辅助治疗状态。

核心结论

  • 现有证据提示,因头颈癌接受TORS的患者治疗后生活质量和吞咽结局良好,但结局取决于基线功能、T分期和辅助治疗状态。

研究设计与样本

  • 系统综述,检索PubMed和Ovid电子数据库自建库至2016年7月6日,由2名独立审阅者按预定纳入标准筛选文献,并手工检索相关文章参考文献。
  • 共筛选103篇文章,最终纳入20篇报告经验证的生活质量和/或吞咽结局指标的文章,涉及659例患者。

主要发现

  • 纳入的20篇研究中,14篇为观察性研究或病例系列,未将TORS组与其他干预进行比较。
  • 2篇为前瞻性非随机临床试验,比较TORS与首选放化疗的结局。
  • 4篇为队列研究,比较TORS与其他治疗方式(包括开放手术和经口激光显微手术)。
  • 总体而言,多数接受TORS±辅助治疗的患者报告在治疗后6至12个月恢复基线生活质量和吞咽功能。
  • 若干研究显示,与首选放化疗或开放手术相比,TORS的生活质量和吞咽结局更优。

关键数值与推荐

  • 纳入标准为报告经验证的生活质量和/或吞咽结局指标的文章。
  • 共纳入20篇文章,涉及659例患者。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To systematically review the available evidence on the effects of transoral robotic surgery (TORS) on the posttreatment quality of life (QOL) and swallow function of patients with head and neck cancer. DATA SOURCES: PubMed and Ovid electronic databases were searched from inception to July 6, 2016. Specific database functions were applied to maximize the search. REVIEW METHODS: Articles in the database were reviewed for inclusion by 2 independent reviewers according to predetermined eligibility criteria. The references of relevant articles were then hand-searched to identify additional manuscripts. For included articles, the study characteristics and relevant data were extracted. RESULTS: Of 103 articles screened, 20 reporting validated measures of QOL and/or swallow outcomes for 659 patients were eligible for inclusion. Fourteen were observational studies or case series and did not compare the TORS group with another intervention. Two were prospective nonrandomized clinical trials that compared outcomes between TORS and primary chemoradiation. Four were cohort studies comparing TORS with other treatment approaches and modalities, including open surgical approaches and transoral laser microsurgery. Overall, most patients who underwent TORS ± adjuvant therapy reported a return to baseline QOL and swallow function by 6 to 12 months posttreatment. Several studies demonstrated superior QOL and swallowing outcomes when compared with primary chemoradiation or open approaches. CONCLUSIONS: Available evidence suggests that patients who undergo TORS for head and neck cancer have good QOL and swallowing outcomes after treatment, but outcomes are dependent on baseline function, T stage, and adjuvant treatment status.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Castellano A, Sharma A. Systematic Review of Validated Quality of Life and Swallow Outcomes after Transoral Robotic Surgery. Otolaryngol Head Neck Surg. 2019. PMID: 31013186. doi:10.1177/0194599819844755

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。